ReviewOncology letters2026
Dual role of exosomes in pancreatic cancer: Underlying mechanisms and research advances (Review).
Review in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic cancer is one of the most common malignant tumors. Due to late diagnosis and a lack of effective treatments, pancreatic cancer has a poor prognosis and a high mortality rate. Further understanding of the mechanisms underlying the development and progression of pancreatic cancer is key to developing rational diagnostic and therapeutic strategies. Exosomes are small vesicles secreted by most cells, carrying a rich cargo of lipids, proteins and nucleic acids. Exosomes serve various roles in intercellular communication, biological processes and signal transduction. Notably, exosomes exhibit a dual role in pancreatic cancer: Exosomes can directly promote tumor cell proliferation, growth and metastasis, modulate the complex immunosuppressive microenvironment and contribute to chemoresistance; by contrast, exosomes can serve as biomarkers for diagnosis and drug delivery vehicles. The present study systematically reviewed the mechanisms through which exosomes exert their dual functions via their specific biomolecular cargo in pancreatic cancer, as well as their potential applications in diagnosis and treatment, thereby laying a research foundation for exosomes to potentially serve a more active role in pancreatic cancer in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.